Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus.
Welsh Transplant Research Group, Cardiff, United Kingdom.
I
I
Quiroga
G
G
Morris-Stiff
R
R
Baboo
C R
CR
Darby
R H
RH
Lord
W A
WA
Jurewicz
D015415:Biomarkers / Q000097:blood; D003324:Coronary Artery Disease / Q000209:etiology; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000601:surgery; D016030:Kidney Transplantation; D011446:Prospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D015415:Biomarkers; D007166:Immunosuppressive Agents; D006710:Homocysteine; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus